Phibro Animal Liabilities And Stockholders Equity Over Time
| PAHC Stock | USD 24.14 0.40 1.68% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Phibro Animal Performance and Phibro Animal Correlation. Phibro |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Dividend Share 0.48 | Earnings Share 0.43 | Revenue Per Share 25.843 | Quarterly Revenue Growth 0.126 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Liabilities And Stockholders Equity Analysis
Compare Phibro Animal Health and related stocks such as Capricor Therapeutics, Soleno Therapeutics, and Bio Path Holdings Liabilities And Stockholders Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPR | 283 | 1.4 M | 227.1 K | 5.5 M | 13.6 M | 16.1 M | 18.7 M | 16.3 M | 9.2 M | 11.1 M | 34.6 M | 41.3 M | 50.1 M | 58.7 M | 61.7 M |
| SLNO | 2.5 M | 2.5 M | 2.5 M | 1.6 M | 8.4 M | 8.2 M | 5.6 M | 39 M | 43.2 M | 38.2 M | 65 M | 35.6 M | 26.5 M | 180.7 M | 189.7 M |
| BPTH | 150.1 K | 3.2 M | 2.3 M | 5.1 M | 15.5 M | 10.8 M | 12.2 M | 8.9 M | 2.3 M | 22.7 M | 16.5 M | 26.6 M | 16 M | 3.2 M | 3.1 M |
| MBRX | 28.1 K | 28.1 K | 28.1 K | 28.1 K | 28.1 K | 28.1 K | 16.4 M | 19.5 M | 19.6 M | 25.2 M | 29 M | 84.1 M | 57.4 M | 38.2 M | 35.4 M |
| CRNX | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 15.6 M | (32.2 M) | (80.6 M) | (153.1 M) | (256.2 M) | (403.3 M) | 635.4 M | 667.1 M |
| ASMB | 870.4 K | 37 M | 20.6 M | 27.1 M | 71.2 M | 133.7 M | 98.1 M | 169.3 M | 268 M | 339.9 M | 283.3 M | 191.1 M | 101.8 M | 137.5 M | 130.2 M |
| TIL | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 9.5 M | 319 M | 610 M | 482.1 M | 325.6 M | 384.2 M |
| CTMX | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 73.1 M | 197.2 M | 199.1 M | 397.6 M | 457.1 M | 341.3 M | 358.7 M | 339.4 M | 260.9 M | 201.8 M | 284 M |
| ACHL | 105.2 M | 105.2 M | 105.2 M | 105.2 M | 105.2 M | 105.2 M | 105.2 M | 105.2 M | 105.2 M | 105.2 M | 218.9 M | 317.1 M | 220.4 M | 161.5 M | 225.1 M |
Phibro Animal Health and related stocks such as Capricor Therapeutics, Soleno Therapeutics, and Bio Path Holdings Liabilities And Stockholders Equity description
The total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation.My Equities
My Current Equities and Potential Positions
| Phibro Animal Health | PAHC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New Jersey; U.S.A |
| Exchange | NASDAQ Exchange |
USD 24.14
Check out Phibro Animal Performance and Phibro Animal Correlation. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Phibro Animal technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.